ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.770,83
2,35%
Brent Oil
83,76
0,67%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Myovant Sciences Ltd (MYOV)

  7. Myovant Sciences Ltd (MYOV) Notícias

MYOV

Myovant Sciences (MYOV)

Myovant Sciences Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:MYOV
DataHoraFonteTítuloCódigoCompanhia
20/03/202314:59Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NYSE:MYOVMyovant Sciences Ltd
17/03/202307:03Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:MYOVMyovant Sciences Ltd
10/03/202311:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MYOVMyovant Sciences Ltd
10/03/202311:32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:MYOVMyovant Sciences Ltd
10/03/202311:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:MYOVMyovant Sciences Ltd
10/03/202311:30Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NYSE:MYOVMyovant Sciences Ltd
10/03/202311:11Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MYOVMyovant Sciences Ltd
16/02/202319:02Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NYSE:MYOVMyovant Sciences Ltd
16/02/202318:39Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:MYOVMyovant Sciences Ltd
14/02/202318:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:MYOVMyovant Sciences Ltd
09/02/202309:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:MYOVMyovant Sciences Ltd
06/02/202316:37Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NYSE:MYOVMyovant Sciences Ltd
26/01/202318:14Edgar (US Regulatory)Quarterly Report (10-q)NYSE:MYOVMyovant Sciences Ltd
26/01/202318:05GlobeNewswire Inc.Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022NYSE:MYOVMyovant Sciences Ltd
23/01/202318:47Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NYSE:MYOVMyovant Sciences Ltd
06/01/202318:10Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NYSE:MYOVMyovant Sciences Ltd
16/12/202210:00PR Newswire (US)MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant SciencesNYSE:MYOVMyovant Sciences Ltd
09/12/202208:09Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NYSE:MYOVMyovant Sciences Ltd
08/12/202219:00Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NYSE:MYOVMyovant Sciences Ltd
16/11/202218:45GlobeNewswire Inc.Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08NYSE:MYOVMyovant Sciences Ltd
16/11/202208:45GlobeNewswire Inc.Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human ResourcesNYSE:MYOVMyovant Sciences Ltd
26/10/202209:30GlobeNewswire Inc.Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022NYSE:MYOVMyovant Sciences Ltd
24/10/202217:30GlobeNewswire Inc.Myovant Sciences Cancels Second Quarter Earnings Conference CallNYSE:MYOVMyovant Sciences Ltd
24/10/202208:30TipRanksMyovant (MYOV) Stock Rising on Acquisition NewsNYSE:MYOVMyovant Sciences Ltd
24/10/202200:36GlobeNewswire Inc.Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive AgreementNYSE:MYOVMyovant Sciences Ltd
21/10/202218:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:MYOVMyovant Sciences Ltd
14/10/202211:02GlobeNewswire Inc.CORRECTION -- Myovant Sciences, Inc.NYSE:MYOVMyovant Sciences Ltd
14/10/202207:45GlobeNewswire Inc.Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.NYSE:MYOVMyovant Sciences Ltd
03/10/202205:24TipRanksMyovant Sciences Rejects Sumitovant’s $2.4 Billion Acquisition OfferNYSE:MYOVMyovant Sciences Ltd
02/10/202220:36GlobeNewswire Inc.Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining SharesNYSE:MYOVMyovant Sciences Ltd
 Apresentando as notícias mais relevantes sobre:NYSE:MYOV

Seu Histórico Recente

USOTC
SOFE
CarePay (CE)
BIT
SCAC7L
SG Issuer Societe Generale
TG
TNE5
Telefonica
GATE
POWRETH
PowerLedger
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados